Welcome to our dedicated page for Altria Group SEC filings (Ticker: MO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Altria Group, Inc. filings document formal disclosures for a U.S. tobacco and nicotine-products operating company. Form 8-K reports cover quarterly and annual results, consolidated financial statements, internal control reporting, material governance changes and completed debt issuances. The filings identify registered securities including MO common stock and exchange-listed notes, and describe senior unsecured notes and guarantees by Philip Morris USA.
Proxy materials cover annual meeting voting matters, director elections, board practices, executive compensation and pay-versus-performance disclosures. The record also includes capital-structure and financial-reporting disclosures tied to Altria's operating subsidiaries, shareholder returns, tobacco and health litigation items, FDA-regulated smoke-free products and other matters affecting its regulated consumer-products business.
Altria Group director Debra J. Kelly Ennis sold shares in a routine open-market transaction. On May 26, 2026, she sold 5,790 shares of Altria common stock at a weighted average price of $72.2483 per share, in multiple trades between $72.24 and $72.26. After these sales, she directly owned 73,809 Altria shares. The filing also notes deferred stock held in the Stock Compensation Plan for Non-Employee Directors.
ALTRIA GROUP, INC. director Ellen R. Strahlman reported an open-market sale of 2,000 shares of common stock on May 26, 2026. The shares were sold at a weighted average price of $72.559 per share, in multiple trades ranging from $72.50 to $72.61.
Following this transaction, Strahlman directly holds 25,102 shares of Altria common stock and also has deferred stock credited under the Stock Compensation Plan for Non-Employee Directors.
Altria Group, Inc. filed Amendment No. 1 to its annual report to add the consolidated financial statements of its foreign equity investee, Anheuser-Busch InBev SA/NV (ABI), as required by Rule 3-09 of Regulation S-X. These ABI statements were audited under Public Company Accounting Oversight Board standards.
The amendment does not change Altria’s own consolidated financial position, results of operations, cash flows, or other disclosures. As of June 30, 2025, Altria’s common stock held by non-affiliates had an aggregate market value of approximately $98 billion, and 1,671,898,087 common shares were outstanding at February 13, 2026.
Fidelity Investments submitted an amended Form 144/A showing proposed sales of Common shares tied to stock awards. The filing lists two award entries: 2,571 shares dated 05/14/2026 and 3,219 shares dated 05/15/2025, each described as Stock Award for compensation.
Altria Group, Inc. detailed new compensation packages for its incoming CEO and CFO and outlined retirement and consulting arrangements for its former CEO. Salvatore Mancuso, now CEO and a salary band A employee, will receive a $1,350,000 annual base salary, a grant of 40,634 restricted stock units and 37,246 performance stock units vesting in 2031, plus incentive and long-term equity targets tied to multi-year performance cycles. Heather A. Newman, the new CFO and a salary band B employee, will receive an $800,000 base salary with incentive and LTIP targets aligned to her band.
Former CEO William F. Gifford, Jr. will receive pro-rated incentive payments and cash in lieu of unvested RSUs and PSUs, with aggregate illustrative values of $6,859,062 for RSUs and $7,837,712 for PSUs at target performance, while forfeiting future equity eligibility. He will also serve as a consultant from May 15 through December 31, 2026 at $250,000 per month. Shareholders elected 10 directors, ratified PricewaterhouseCoopers LLP as auditor, and approved, on an advisory basis, compensation for named executive officers.
Strahlman Ellen R reported acquisition or exercise transactions in this Form 4 filing.
ALTRIA GROUP, INC. director Ellen R. Strahlman reported a compensation-related equity award rather than an open-market trade. She received a grant of 2,571 shares of common stock at a price of $0.00 per share, described as deferred stock under the 2025 Stock Compensation Plan for Non-Employee Directors.
After this grant, she directly holds 27,102 shares of common stock. She also holds phantom stock units tied on a 1-for-1 basis to the value of Altria’s common stock, representing 14,795 underlying shares, which are distributable in cash under director fee and stock compensation plans.
Altria Group director Richard S. Stoddart reported a grant of 2,571 shares of deferred common stock under the 2025 Stock Compensation Plan for Non-Employee Directors. The award was recorded at a price of $0.00 per share, reflecting compensation rather than an open-market purchase.
After this grant, Stoddart directly holds 6,010 deferred shares in the plan, which the footnotes state includes an increase of 220 shares acquired through the reinvestment of dividends on deferred shares since May 15, 2025, the date of the last reportable transaction. He also reports 40 shares of common stock held indirectly by his spouse in trust.
Altria Group director Ian L.T. Clarke received an award of 2,571 shares of common stock on May 14, 2026 as a grant under the 2025 Stock Compensation Plan for Non-Employee Directors. The award was priced at $0.00 per share, reflecting equity compensation rather than a market purchase.
After this grant, Clarke directly holds 18,618 Altria shares, which include 15,319 deferred shares in the Stock Compensation Plan for Non-Employee Directors. That deferred balance reflects 817 additional shares and 136 investment account shares acquired through dividend reinvestment since the prior reportable date.